Aristotle Atlantic Partners, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 148 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2020. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
Aristotle Atlantic Partners, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$16,667,223
-20.0%
3,058,206
-1.5%
0.67%
-15.0%
Q2 2023$20,834,288
+23.7%
3,104,961
+62.8%
0.78%
-9.4%
Q1 2023$16,839,596
+17.2%
1,907,089
+1.4%
0.87%
+7.6%
Q4 2022$14,367,532
+6.5%
1,880,567
-0.7%
0.80%
-1.9%
Q3 2022$13,488,000
+25.4%
1,894,395
+42.5%
0.82%
-0.7%
Q2 2022$10,754,000
+2.0%
1,329,268
+75.0%
0.83%
+26.8%
Q1 2022$10,541,000
-49.6%
759,412
+1.8%
0.65%
-46.3%
Q4 2021$20,927,000
-15.4%
745,795
+2.5%
1.22%
-25.7%
Q3 2021$24,722,000
-15.7%
727,334
+1.3%
1.64%
-15.4%
Q2 2021$29,323,000
+27.6%
717,650
+25.7%
1.93%
+15.1%
Q1 2021$22,986,000
-29.1%
570,942
+4.1%
1.68%
-32.8%
Q4 2020$32,426,000
+25.5%
548,380
+3.2%
2.50%
+10.0%
Q3 2020$25,830,000
+4.3%
531,145
+3.8%
2.28%
-4.3%
Q2 2020$24,758,000
+140.3%
511,732
+38.0%
2.38%
+51.2%
Q1 2020$10,302,000
-5.3%
370,841
+2.0%
1.57%
+13.2%
Q4 2019$10,879,000
+597.8%
363,609
+620.6%
1.39%
+209.4%
Q3 2019$1,559,00050,4590.45%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2020
NameSharesValueWeighting ↓
Matrix Capital Management Company, LP 15,115,090$419,897,00010.74%
TIGER MANAGEMENT L.L.C. 1,115,411$30,986,00010.41%
Robertson Stephens Wealth Management, LLC 537,095$14,920,0005.10%
VIKING GLOBAL INVESTORS LP 33,493,708$930,455,0004.84%
Senator Investment Group LP 3,388,085$94,121,0003.41%
Casdin Capital, LLC 793,125$22,033,0002.34%
Iron Triangle Partners LP 150,000$4,167,0001.61%
Aristotle Atlantic Partners, LLC 370,841$10,302,0001.57%
Crewe Advisors LLC 93,000$2,584,0001.54%
PERSONAL CFO SOLUTIONS, LLC 112,916$3,137,0001.13%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders